Trans unsaturated fatty acids are less oxidizable than cis unsaturated fatty acids and protect endogenous lipids from oxidation in lipoproteins and lipid bilayers.
Epidemiological data suggest that dietary trans unsaturated fatty acids increase the risk of heart disease; however, the underlying mechanisms are unclear. In this study, we investigated one possible mechanism, namely, their effect on LDL oxidation. Supplementation of LDL with 10% 16:1 trans-cholesteryl ester (CE) inhibited the oxidation compared to that with 16:1 cis-CE. Total replacement of core lipids with 18:2 trans,trans-CE decreased the rate of LDL oxidation by 19% compared to replacement with 18:2 cis,cis-CE. When the surface phosphoglycerides were replaced with either 16:0-18:2 cis,cis-phosphatidylcholine (PC) or 16:0-18:2 trans,trans-PC, the latter was found to inhibit the rate and increase the lag time of oxidation to a greater extent than the former. To confirm these findings, we studied the oxidation of PC liposomes by assessing the formation of conjugated dienes or the degradation of a fluorescently labeled PC. By both methods, the 16:0-18:2 trans,trans-PC exhibited greater resistance to oxidation than the 16:0-18:2 cis,cis-PC. Eliminating the fluidity differences did not completely eliminate the differences in oxidation rates, suggesting that the trans double bond is inherently resistant to oxidation. The composition of the conjugated hydroperoxy products formed after oxidation differed markedly for the two 18:2 isomers. Supplementation of 16:0-18:2 cis,cis-PC liposomes with 20 mol % di16:1 trans-PC retarded oxidation rates to a greater extent than supplementation with di16:1 cis-PC. These studies show that dietary trans unsaturated fatty acids decrease the rate of lipid peroxidation, an effect that may mitigate the atherogenic effect of these fatty acids.
D000466:Alkadienes / Q000032:analysis / Q000737:chemistry; D000578:Amidines / Q000737:chemistry; D002788:Cholesterol Esters / Q000737:chemistry / Q000494:pharmacology; D019327:Copper Sulfate / Q000737:chemistry; D004952:Esters / Q000032:analysis / Q000737:chemistry; D005231:Fatty Acids, Unsaturated / Q000737:chemistry* / Q000494:pharmacology; D020404:Glycerophospholipids / Q000737:chemistry; D007536:Isomerism; D008051:Lipid Bilayers / Q000737:chemistry* / Q000378:metabolism; D050356:Lipid Metabolism; D008054:Lipid Peroxides / Q000032:analysis; D008055:Lipids / Q000737:chemistry*; D008077:Lipoproteins, LDL / Q000737:chemistry* / Q000378:metabolism; D008081:Liposomes / Q000737:chemistry; D008567:Membranes, Artificial; D010084:Oxidation-Reduction; D010713:Phosphatidylcholines / Q000737:chemistry; D013050:Spectrometry, Fluorescence / Q000379:methods; D013696:Temperature
D000466:Alkadienes; D000578:Amidines; D002788:Cholesterol Esters; D004952:Esters; D005231:Fatty Acids, Unsaturated; D020404:Glycerophospholipids; D008051:Lipid Bilayers; D008054:Lipid Peroxides; D008055:Lipids; D008077:Lipoproteins, LDL; D008081:Liposomes; D008567:Membranes, Artificial; D010713:Phosphatidylcholines; C046728:2,2'-azobis(2-amidinopropane); D019327:Copper Sulfate